The US Food & Drug Administration has approved the abbreviated new drug application filed by Granules Pharmaceuticals, Inc., a wholly owned foreign subsidiary of Granules India for Amphetamine Sulfate Tablets USP 5 mg and 10 mg.
Tuesday 6 August 2019
Indiabulls Real Estate Clarifies on Embassy Group Deal
The US Food & Drug Administration has approved the abbreviated new drug application filed by Granules Pharmaceuticals, Inc., a wholly owned foreign subsidiary of Granules India for Amphetamine Sulfate Tablets USP 5 mg and 10 mg.
Subscribe to:
Post Comments (Atom)
Trends On SGX Nifty Indicate A Positive Opening For The Broader Index In India
Trends on SGX Nifty indicate a positive opening for the broader index in India, with a 31.5 points gain or 0.25 percent. The Nifty future...
-
Benchmark indices are trading higher in the pre-opening trade on Thursday. The Sensex is up 66.14 points or 0.17% at 38199.02, and the Ni... -
The Sensex is up 171.44 points at 38404.85, while Nifty is up 40.50 points at 11523.80. About 559 shares have advanced, 239 shares declin... -
Maruti Suzuki India share price added 1.5 percent in the early trade on December 17 after foreign research house Bank of America Merrill ...
No comments:
Post a Comment